Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,209,843
in 4 filings, $2.2M under 10b5-1 plans

Net −$5,209,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-30 RA CAPITAL MANAGEMENT, L.P. Director Purchase +58,300 $24.16 $1.4M 5,825,521
2026-03-27 RA CAPITAL MANAGEMENT, L.P. Director Purchase +310,700 $23.67 $7.4M 5,767,221
2026-02-19 RA CAPITAL MANAGEMENT, L.P. Director Grant or award +6,200 6,200
2026-02-19 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +8,300 8,300
2025-09-04 RA CAPITAL MANAGEMENT, L.P. Director Purchase +1,176,470 $25.50 $30.0M 5,456,521
2025-03-13 RA CAPITAL MANAGEMENT, L.P. Director Purchase +1,296,296 $13.50 $17.5M 4,280,051
2025-02-13 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +32,900 32,900
2024-05-22 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option +22,000 22,000
2024-02-12 RA CAPITAL MANAGEMENT, L.P. Director Grant or award +1,672,508 $13.50 $22.6M 2,983,755
2024-02-12 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Pre-Funded Warrants (Right to Buy) +549,755 $13.50 $7.4M 549,755
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion +1,735,629 1,735,629
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Purchase +131,600 $16.00 $2.1M 1,867,229
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion +192,847 192,847
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Purchase +1,118,400 $16.00 $17.9M 1,311,247
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series B Preferred Stock −1,735,629 0
2023-02-14 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series B Preferred Stock −192,847 0
2023-02-09 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option +44,000 44,000

Page 1 of 1 · 17 trades